U.S. still faces possible default wave, asset declines due to pandemic: Fed

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PCVX
2. PTC
3. NVDA
4. SPY
5. META
6. MSFT
7. GOOGL
8. GMAB
9. BETR
10. BBIO

Go back to U.S. still faces possible default wave, asset declines due to pandemic: Fed

Pfizer (PFE) Reports Positive Results from Fifth Phase 3 Trial of Abrocitinib

November 11, 2020 6:46 AM EST

Pfizer Inc. (NYSE: PFE) announced today positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients 12 and older with moderate to severe atopic dermatitis (AD) following response to initial open label induction treatment with abrocitinib 200mg. Patients were randomized... More